We were able to successfully target the tumour within 24 h after injection and demonstrated that [89Zr]DFO-anti-PDL1 can be used for the non-invasive imaging of the CMT167 lung cancer tumour in a syngeneic mice model. This evidence concerns the gene CD274 and neoplasm.